Although the present study did not reveal any significant improvements in glycemic control, insulin resistance, cardiovascular markers, or anthropometry after three months of brief MM treatment, it did find that patients with central obesity exhibited statistically significant reductions in HbA1c, with a magnitude comparable to the benefits of aerobic exercise. The gene discussed is INS; the disease is Abdominal obesity.